Lapatinib Terminated Phase 0 Trials for Bladder Carcinoma / Cystectomy / Infiltrative Bladder Carcinoma

IndicationsStatusPurposePhase
TerminatedNot Available0
clinicaltrials.gov IdentifierTitleDrugs
NCT01245660A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy